American Regent, Inc., a Daiichi Sankyo Group company, today announced results from the phase 3 HEART-FID trial of INJECTAFER® (ferric carboxymaltose injection) for the treatment of iron deficiency in adult heart
The largest ever study of IV iron supplementation in patients with heart failure failed to meet a new rigorous definition of significance, and the results were generally regarded as disappointing.
Save the Children and Daiichi Sankyo in collaboration with the Department of Health, Pediatric and Obstetrics Hospital of Yen Bai province, on July 4 organised a project launching workshop, aiming to protect maternal and child health in the mountainous ar